The highest mortality rate due to breast cancer in the US is seen in black women and the lowest in Asian American Pacific ...
Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...
Airway Therapeutics is to launch a Phase III trial of zelpultide alfa, a drug to prevent bronchopulmonary dysplasia in ...
MSD will provide KEYTRUDA for the Exelixis-sponsored Phase III STELLAR-305 trial. Credit: JeanLucIchard/Shutterstock. US-based biotechnology companies Exelixis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback